Royal National Orthopaedic Hospital NHS Trust New Theatre Business Case For Approval Summary This business case establishes the rationale for the Trust to invest in: A new modular Theatre facility The refurbishment of Theatre 1 & 2 Explore the possibility of converting Theatre 3 to a new centralised Theatre Storage Facility Key Outcomes: On completion of the preferred option the key outcomes will be : Provision of additional theatre capacity Elimination of critical backlog maintenance issues associated with Theatres 1&2 Facilitation a robust programme of theatre maintenance which will not be interrupted by service demand pressures Improved efficiency and financial control, through centralisation of supplies and equipment within the theatre complex The Trust Board is asked to approve the project and authorise the following funding: Capital Costs: 1. Infrastructure and enabling work (including IT infrastructure) 2. New modular Theatre 3. Theatres 1 & 2 refurbishment 4. Theatres 1 & 2 refurbishment 5. Theatre 3 conversion to a potential central store and enhancement of changing facilities, office space reconfiguration and rest areas. Total Capital Costs £586,000 Funding Year 2009/10 £938,000* £510,000 £785,000 £483,000 2009/10 2009/10 2010/11 2010/11 £3,302,000 * The above represents the capital costs of purchasing a new modular theatre. However, leasing is the currently the only option as there is insufficient scope within the capital programme to cover such a significant outlay without compromising other capital requirements such as medical equipment. A loan facility with the department of Health is also being explored as this may provide a cheaper financing option than leasing. Although it will not affect construction of the new theatre, a final decision on the financing solution will be made before work on the new theatre begins. Page 1 of 14 1. INTRODUCTION 1.1 CONTEXT AND BACKGROUND TO THE BUSINESS CASE 1.1 In 2004 a Business Case for the installation of twin modular leased operating theatres (Theatres 9 & 10) to allow the refurbishment of Theatres 1 & 2 was approved. This Business Case did not result in the closure and refurbishment of Theatres 1 & 2 due to activity increases which necessitated the need to keep Theatre 1 operational and the requirement to use Theatre 2 as a storage area. 1.2 This Business Case: Highlights the need to provide a new modular Theatre Facility, undertake refurbishment of Theatres 1 & 2 and to create a centralised Theatre Storage Facility; Seeks to secure funding to ensure surgical activity will be carried out in an environmentally safe and regulatory compliant setting; Will increase theatre capacity to support the 18 week referral to treatment (RTT) pathway; Clearly demonstrates that patients and staff will benefit from a safer environment with reduced risk of infections and reduced clinical incidents; Will deliver improved financial control over theatre procurement and storage; Will improve security arrangements and staff facilities within the Theatre complex. 2. SUMMARY OF CURRENT THEATRE SERVICES 2.1 The Trust currently has a Theatre complex consisting of 9 Theatres with only 8 operational (Theatres 1, 3 5, 6, 7, 8, 9 and 10). Theatre 2 is currently being used for storage by sterile services. 2.2 There is operating capacity of up to 80 elective sessions Monday to Friday, 6 sessions on a Saturday and 15 overrun sessions a week. 2.3 The Trust is currently recruiting and appointing the following consultant posts, all of whom will require increasing theatre time: Spinal consultant Spinal consultant Shoulder consultant Joint Reconstruction consultant Paediatric consultant - New post - Replacement post - Replacement post - New post - New post The Trust also needs to provide two sessions for emergency lists and one additional session for paediatric work. Page 2 of 14 3. CASE FOR CHANGE 3.1 ESTATE CONDITION OF THEATRES 1 & 2 3.1.1 Theatres 1 & 2 were built in 1962 and since that date only a minimal amount of refurbishment work has been carried out. The Trust is now at the stage where the refurbishment of Theatre 1 cannot be delayed as it is failing to deliver a safe and reliable service and does not comply with the relevant standards such as: HTM 07 ( Health Technical Memorandum) HTM 04 HBN 26 ( Health Building Note) UK and European legislation and guidance (Infection control) The Hygiene Code HTM 03 HTM 06 BS 5226 ( British Standard) BS 6651 3.1.2 Theatre 2 has not been in use for a number of years and with the demand pressures the Trust is facing, bringing this asset back up to standard to allow more operations to be completed makes good business sense. 3.1.2 However, extensive work is required to bring them up to an acceptable standard as shown in the Table 1: Table 1: Estatecode six facet performance – Theatres 1 & 2 A - Meets modern standards. B – Acceptable. C - Below standard. D – Unacceptable. Category A Category B Category C Category D Building 0% 5% 90% 5% Condition Electrical 0% 20% 40% 40% Condition Mechanical 0% 25% 37% 38% Condition 3.1.3 The combination of all these factors creates a potential clinical risk to patients and staff and ultimately a business risk. The additional capacity is also required to enable an annual programme of theatres validation to ensure that ventilation systems are tested for microbiological performance. The Trust has been unsuccessful over the past five years in developing a robust annual validation programme due to waiting list pressures. 3.1.4 The estate case for change can be summarised as follows: Inadequate environmental conditions Plant health risks and potential failures Potential risks to patient care and good clinical outcomes Potential risks to staff working in the environment Increased infection rates, due to the Theatres not being ultra clean ventilated as recommended in HTM 2025 and HTM03 Backlog maintenance liability and increasing costs in maintaining poorly constructed facilities Prosecution due to failure to comply with statutory health and safety regulations Page 3 of 14 3.2 FUTURE WORKLOAD AND CAPACITY REQUIREMENTS 3.2.1 An activity modelling and forecasting exercise was undertaken as part of the Outline Business Case Addendum for Redevelopment which concluded that that the Trust had seen an average year-on-year growth of 5% with an expectation is that activity will continue to grow at a similar level. 3.2.2 This was just to keep on top of current 18 week referral to treatment pathway demand and did not make a significant allowance for dealing with the growing backlog of cases, introducing the full patient choice menu of services as well as keeping on top of the general increase in specialist orthopaedic service referrals as a result of changes in the market the Trust operates. Although this has not been properly evidenced, part of the increase in demand is felt to be due the NHS’s success with the 18 week target and the public not opting for private healthcare as in the past. 3.2.3 To further enhance the case for an additional theatre, at the end of September 2009 the volume of backlog was running at 207 patients waiting to be treated and 448 patients waiting for a decision to be treated. To get through this backlog will take a minimum of 6 months of theatre time assuming an average of 5 cases can be dealt with on a daily basis and the theatre has no down-time, which in reality is unlikely. 3.2.4 Keeping on top of this situation has only been possible with the use of the independent sector, which the Trust has sourced extra capacity from Spire and the HCA Group for joints, shoulder and spinal work. The possibility of working with another Trust under a ‘hub’ and ‘spoke’ model of care is still an option, but due to capital financing constraints, this is looking increasingly unlikely in the short-term to deliver a solution. 3.2.5 Therefore going forward, and planning on the basis that referral rates will continue to grow at the historical levels of growth, i.e. 5%, the Trust can expect an additional 530 cases per annum based on the current years plan. This along with bringing back the 250 cases the independent sector is planning to undertake on behalf of the Trust in 2009/10, ensures that there will be sufficient activity after the initial backlog is cleared to sustain the viability of the additional theatre. 3.2.2 In summary, the service case for change can be summarised as follows: The Trust currently has insufficient capacity to effectively deliver the admitted 18 week trajectory; Capacity issues already exists with the 8 current theatres, leading to the Trust to have a significant backlog of cases building even though the independent sector is being used where possible; The Trust is facing a growing problem with the reductions in consultant operating time due to insufficient capacity. Consultants are increasingly having limited access to theatre sessions which could compromise clinical outcomes and increase overall waiting lists; The recruitment of new consultants requires additional theatre capacity; For various reasons the Trust has experienced an increase in the rates of cancellations of booked patients which with the lack of overall capacity, has put pressure on emergency lists as well as re-arranging the cancellations; Page 4 of 14 Activity growth assumptions contained within the Integrated Business Plan and the RNOH Outline Business Case for redevelopment form the basis of the affordability assumptions, both in terms of being able to support the financing costs of the scheme as well as delivering robust financial plans for the future. 3.3 PROCUREMENT AND STORAGE MANAGEMENT 3.3.1 The key challenges posed by the current procurement and storage arrangement include: Multiple procurement processes in operation making supply management to theatres uncontrolled and inefficient. Stock is held in a number of locations throughout the theatre complex and is susceptible to mis-management and ultimately a cost concern; Equipment and stock is stored in corridors which poses control of infection and fire risks; Product usage information severely limited hampering strategic decisions and control of product selection; A lack of management information relating to product usage, location and cost resulting in the duplication of stock in various locations increasing the potential for obsolescence. 3.3.2 This existing arrangement makes the theatre procurement, replenishing processes, overall logistic flows, storage arrangements and stock levels requirements functionally ineffective and a financial risk. 3.3.3 The proposal going forward is that all stocks are centrally located, supported by an electronic information system and managed through an enhanced stock process. Ideally, this will be in an area easily accessible within the theatre complex and the use of theatre 3 is being explored as an option as this will shortly require significant investment to keep it compliant under the relevant standards contained within section 3. 3.4 FINANCIAL CASE FOR CHANGE 3.4.1 The Trust’s current Business Plan was presented and agreed on the basis that a 5% recurrent increase in baseline activity was required in order to meet the income targets for 2009/10 and onwards. The assumptions going beyond 2009/10 were for modest increases in the activity baseline, but the evidence suggest that this is unlikely and the level of activity growth is likely to remain consistent with the 5% average over the last 3 years. The business plan was supported by the Trust’s workforce plans to recruit additional consultant surgeons and theatre staff to allow the Trust to meet the operational performance targets and patient choice agenda more effectively. Since the business plan was adopted by the Trust Board, the likelihood of reductions in national funding as well as the prospect of delivering more activity for the same amount of funding in the future has surfaced. 3.4.2 As set out in section 3 above, the additional activity requirements have only partially been met through the Trust’s internal resources and a number of cases have been sub-commissioned to the independent sector. This solution is not ideal for the Trust as the contractual arrangements are such that only a small contribution to the Trust’s costs is recovered. As a result, this is not considered a long term solution. Page 5 of 14 3.4.3 Add to this the growing number of backlog cases arising from the new patients the Trust can actually see on a weekly basis and the problem is clear from an operational and clinical perspective. This should however not disguise the fact that an opportunity also exists insofar as a guaranteed source of activity and profit is available if the capacity constraints can be overcome. This will only benefit the Trust by strengthening its financial position and ensuring that future financial plans will be less reliant on delivering significant cost improvement savings and potentially affecting the quality of services provided by the Trust. 3.4.4 In summary, the financial benefits supporting the additional theatre and storage solutions are as follows: 5% increase in activity expected going forward, which translated represents approximately an additional 1,000 operations or 800 discharges. Assuming the case-mix will be delivered on the basis of the consultant appointments, then income of approximately £9million could be expected from a full years activity (see section 5 below); Pressure to meet the 18-week target could be compounded by Commissioners exercising their right to levy a financial penalty. This position would seriously affect morale and defeat all the efforts made by clinical staff to deliver the 18week targets; Using the decommissioned theatre as a store does not make good business sense. The opportunity loss is significant and the Trust could be accused of not sweating its assets sufficiently to deal with its capacity issues. The new theatre will have sufficient space to decant the items from theatre 2 allowing this to be refurbished as soon as possible; Management of stock items has proved difficult to control over the years and remains a major financial risk for the Trust. The project aims to deal with this by having a dedicated stock facility, supported by a new electronic system and redesigned processes to mitigate all the risks currently being experienced. 4. OPTION APPRAISAL 4.1 Description of the options: 4.1.1 Option 1 - Do nothing Do nothing is not a viable option as it combines lack of compliance, risks to the Trust Performance on 18 weeks and length of stay. In addition, there is the possibility that it will destabilise the Trust financially which could ultimately effect both the achievement and continuation of Foundation Trust status. 4.2 Option 2 - Provision of a new storage facility and Theatre 1 & 2 refurbishment The provision of a separate prefabricated storage unit adjacent to Theatres 1 & 2 with plant installed on the roof ready for Theatre 1 & 2 refurbishment which will follow as a second phase. 4.2.2 Timeline The construction of a new central dedicated Theatre Storage Facility could commence in October 2009 with an anticipated completion date of the end of Page 6 of 14 February 2010. Refurbishment of Theatres 1 & 2 would commence in April 2010 and the work will take approximately 3 months to complete thereafter. 4.2.3 Estimated capital costs: Theatre store Theatres 1 & 2 refurbishment Infrastructure and enabling work Total 4.2.4 £828,000 £1,295,000 £541,988 £2,664,988 SWOT Analysis Strengths Weaknesses Enhanced physical layout which will reduce stock holding and enable better stock management Robust alternative capacity solutions will need to be put in place involving a combination of theatre rescheduling and using alternative external providers. (none have been identified by the work stream) Equipment will meet all statutory Health and Safety legislation, regulations and directives Improved access for patients with the ability to meet 18 week referral treatment target post Theatre 1 & 2 refurbishment Work on Theatres 1 & 2 could take longer than 3 months Activity decreases during refurbishment phase resulting in Trust financial downturn Improve environmental quality for patients and a service that does not put patients at risk Provision of an environment that is safe for staff to work in and complies with standards Opportunities Threats Increased capacity through the Theatre 1 not being relinquished for provision of ten extra sessions by refurbishment in order to maintain having nine operating Theatres activity through put. 4.3 Option 3 – A modular new theatre facility, Theatre 1 & 2 refurbishment and conversion of Theatre 3 to a Centralised Store A new modular theatre building with an integral store area to accommodate instrumentation currently stored in Theatre 2 with plant space ready for Theatre 1 & 2 refurbishment. Theatre 1 & 2 refurbishment to follow on as a second phase and finally Theatre 3 converted to create a central store area. 4.3.1 Timeline Work on the installation of a modular theatre would commence in October 2009 and completed by March 2010. Refurbishment of Theatres 1&2 commencing in April 2010 taking approximately 3 months to complete due to less enabling works carried out this financial year in this option. Conversion of Theatre 3 would follow on from this. Page 7 of 14 4.3.2 Estimated capital costs £586,000* £938,000 £510,000 £785,000 £483,000 £3,302,000 Infrastructure and enabling work New modular Theatre Theatres 1 & 2 refurbishment Theatres 1 & 2 refurbishment Theatre 3 conversion to a central store Total 4.4.3 SWOT Analysis Strengths Weaknesses Enhanced physical layout which will Delays the creation of a reduce stock holding and enable better centralised store by up to two stock management years will need Trust commitment that the third stage Equipment will meet all statutory Health of this project will be given and Safety legislation, regulations and priority for capital funding by the directives Trust in 2011/12. Improved access for patients with the Key theatre and supplies ability to meet 18 week referral stakeholders may not engage treatment targets particularly as the storage issues are not immediately resolved No activity pressure due to provision of additional Theatre first with less operational and business risk Improve environmental quality for patients and a service that does not put patients at risk Provision of an environment that is safe for staff to work in and complies with standards Opportunities Increased capacity through the provision of ten Theatres from the third quarter of 2010/11 financial year Threats Theatres may not be relinquished as extra capacity that is created may be required if activity increases materialise 4.2 PREFERRED THEATRE OPTION 4.2.1 On the basis of the above, the Theatre Capacity Steering Group agreed at its meeting held on 19th August 2009, that Option 3 i.e. the provision of a modular new Theatre facility and the refurbishment of Theatres 1 & 2, was the favoured option. 4.2.2 Converting Theatre 3 to a centralised store was also considered the only solution at this stage for the store. However, it was agreed that further investigation into alternative solutions should continue to be explored as time was available to do this. Page 8 of 14 4.3 TIMETABLE 4.3.1 The construction of a new modular theatre will commence in October 2009 and will be completed by no later than March 2010. Although the expectation is that the new theatre will be completed by January 2010, it is dependent on the complexity of the infrastructure and enabling works, which will only become clearer once work commences on the site in October. 4.3.2 The main refurbishment work to Theatres 1 & 2 will commence in April 2010 and be completed by no later than July 2010 (see Appendix A for Capital Project Programme and Theatre Project Plan). 4.3.3 Before April 2010, a final decision will be made on a location for the theatre store, which may be Theatre 3. The plans at present Theatre 3 as the store solution, but this may change. 4.3.4 The table below illustrates that the preferred option does not affect capacity during the works and following completion the Trust will have 9 theatres thus increasing theatre capacity by an additional ten sessions. Description No of Theatres Pre Construction of Modular Theatre 8 Post Construction of modular theatre 9 Closure of Theatres 1 & 2 for 8 Refurbishment Post Refurbishment of Theatres 1 & 2 10 Conversion of Theatre 3 to a store and 9 enhancement of changing facilities, office space reconfiguration and rest areas. Timescale Now to March 2010 March 2010 onwards April 2010 July 2010 October 2010 4.4 WORKFORCE IMPLICATIONS AND COSTS 4.4.1 Table 3 illustrates the staffing requirements for Theatre 2. These are all new posts that will need recruiting to. Table 3: Staffing requirements Staff numbers (wte) Staff costs (£) Consultant Surgeons (Spinal, JRU, Hip Paeds) 3.0 327,435 Consultant Anaesthetists (0.5wte per Surgical appointment) 1.5 184,112 Junior Doctors (1 SHO & 1 SpR for each Surgical appointment) 6.0 423,000 Therapists (1.5 for each Surgical appointment) 4.5 154,845 Theatre Radiographer (Imaging business case) 1.0 37,390 Orthotists 2.0 98,718 Nurses/ODPs - theatres 9.8 396,023 Page 9 of 14 Nurses/HCAs - wards 8.6 277,748 Nurses/HCAs - out-patients 3.0 72,522 Nurses - HDU outreach 3.0 141,431 Admin to support central booking/medical records/medical secretaries/ward clerks 5.6 146,554 Total additional staff required & recurrent cost 48.0 2,260,000 NB: The above staffing requirements have been brought together from the 2 consultant (Spinal & Paeds) and imaging business cases presented to the Trust Board for approval. Final requirements to support the consultant posts will be assessed once operating lists have been finalised. However, the numbers are not expected to alter significantly with only minor skill mix changes. 4.4.2 Recruitment Strategy: 4.4.2.1 The Trust has had a successful recruitment campaign in the Philippines this year, recruiting 25 qualified nurses. These will fill 14 vacancies in both the ‘recovery’ and ‘scrub’ area within theatres. However, given the turnover of staff in theatres, the Trust still has 25 vacancies across all theatres even when the Filipino nurses start their employment. Shortages are particularly acute in the Anaesthetic area and although the Trust plans to initiate a further international recruitment campaign, because of the requirement for an anaesthetic qualification, this group of staff are hard to find. 4.4.2.2 Therefore, in tandem with recruiting internationally we have appointed a clinical educator who will support the development of a competency based approach to training our nurses to the appropriate level of knowledge and skills to practice as an anaesthetic nurse or Operating Department Practitioner (ODP). Nevertheless, once the new theatre is in place we will still be reliant on employing agency staff and in particular ODPs and with the current commission rates being paid this represents an uplift of 7/8% on a normal NHS salary even when on costs are taken into consideration.. 4.5 EQUIPMENT REQUIREMENT 4.5.1 The new modular Theatre will require all new kit and equipment. The costs of these are as follows: 4.5.2 Capital costs: A revised list of requirements has been produced and has been calculated to cost approximately £240,000 plus VAT. This will be met through a combination of the capital programme and I&E budgets, depending on the value of the items. 4.5.3 Revenue costs: Annual revenue costs, i.e. capital charges (depreciation and dividend), have been estimated at £32,000. An assessment of service and maintenance charges is being undertaken, but it is not expected to exceed £20,000 per annum. Page 10 of 14 5 FINANCIAL SUMMARY 5.3 The capital & revenue costs of the project are summarised in Table 4. The costs of the project are current and have been obtained via a formal tender and or Official Government of Commerce financial arrangements to ensure robustness. Staff WTE 2009/10 2010/11 2011/12 £k £k £k 2,150 200 100 0 2,450 6,260 600 500 100 7,260 7,760 700 600 100 9,060 950 2,260 2,260 600 1,800 2,400 400 1,100 1,500 100 200 200 NHS Patient Income In-patient income Out-patient income Unbundled imaging income Unbundled transport income Total income Pay Costs (as above in section 4.4) 48.0 Non-pay Costs Prostheses Other Medical Supplies & Services (including utilities) Theatre lease costs Capital charges (all refurbishment & enabling works) Total non-pay 0 400 500 1,100 3,500 4,600 Sub-total - expenditure 2,050 5,760 6,860 400 1,500 2,200 Surplus 5.4 The financial summary above has allowed for ward configurations to create additional inpatient bed capacity if the need arises. This will be assessed during the latter stages of the refurbishment of Theatres 1 & 2 when a clearer indication of 2010/11 activity will be available. Patient Income Other Income £k 82,110 7,730 Business Case (full year) £k 9,060 0 Total Income 89,840 9,060 99,240 Pay Non-Pay -47,519 -36,248 -2,260 -4,100 -50,119 -40,348 Total Expenditure -83,767 -6,360 -90,467 6,073 6.8% 2,700 8,773 8.8% Income and Expenditure Account (recurrent position) EBITDA EBITDA Margin 2009/10 Plans Page 11 of 14 Impact on Current plans £k 91,510 7,730 Depreciation Interest & Finance Costs PDC Dividends Paid Retained Surplus I&E Surplus Margin -3,330 -14 -1,773 -400 0 -100 -3,730 -14 -1,873 956 2,200 3,156 1.06% 3.18% Summary Balance Sheet Total Non-Current Assets 62,709 1,723 64,432 Total Current Assets Total Current Liabilities 11,503 -9,902 1,415 0 12,918 -9,902 1,601 1,415 3,016 -417 -478 -938 0 -1,355 -478 Total Assets Employed 63,415 2,200 65,615 Public dividend capital Income and expenditure reserve Revaluation reserve Donated asset reserve 24,329 3,501 24,658 10,927 0 2,200 0 0 24,329 5,701 24,658 10,927 Total Funds Employed 63,415 2,200 65,615 Return on Assets (ROA) 4.33% 3.59% 7.84% Net Current Assets Creditors: >1 year Provisions (liabilities & charges) Liquidity Ratio 10.63 10.91 2009/10 Plans Business Case Impact Weighted Average Risk Rating 3 5 3 2 3 3 5 5 2 4 Overriding rules: One financial criterion scored at '2' OVERALL RATING 3 3 3 3 Financial Risk Rating Financial Criteria: Underlying Performance (EBITDA margin) Achievement of Plan (EBITDA % achieved) Financial Efficiency (Average of ROA + I&E surplus margin) Liquidity 6. BENEFITS REALISATION 6.1 The following benefits have been identified in relation to the refurbishment of Theatres 1 & 2: Page 12 of 14 Equipment will meet all statutory Health and Safety legislation, regulations and directives Improved access for patients with the ability to meet 18 week referral treatment target Improve environmental quality for patients and service that does not put patients at clinical risk Provision of an environment that is safe for staff to work in and complies with Health and Safety legislation, EC directives and building regulations Increased capacity through the provision of ten extra sessions. 6.2 The new centralised storage facility will provide an enhanced physical layout which will reduce stock holding due to the elimination of unnecessary duplicate stocking locations. It will also improve stock management systems enabling application of ‘just in time’ supplies methodology with greater control of non-stock/speciality product deliveries and reducing the possibility of lost deliveries and misplaced stock. 6.3 It will also support enhanced management information - enabling the Trust to further improve efficiency in procurement and supply through increased Trust awareness of total acquisition cost for theatres. 7 RISKS 7.2 This Business Case demonstrates a very strong case for investment. The scenario without change is one of crisis management and ultimately the risk to the continued provision of services. The following high level risks have been identified if the Trust does not approve the investment: Patient care risks Increased infection rates Potential estate related serous untoward incidents Electrical and/or mechanical breakdown Environmental and plant risks Inadequate ventilation systems with no ultra clean air handling Air handling unit failure Electrical failure Risk associated to Trust Business Prosecution due to failure to comply with basic standards Prolonged cancellation of operations due to plant failure Failure to achieve waiting list targets Failure to achieve financial targets 8 PLANNING AND IMPLEMENTATION ARRANGEMENTS 8.2 A project Steering Committee has been convened who will be accountable to the Trust Board for successful implementation; the project structure is illustrated in Figure 1. Page 13 of 14 Figure1: Theatre Capacity Project Structure 8.3 The Trust is planning to recruit a Service Development Project Manager on a fixed term contract for 12 months to lead the project. The post holder will have responsibility for ensuring there are robust and comprehensive plans covering all aspects of theatre capacity service development project to ensure the Trust achieves its service development aspirations and will act as the prime interface with the Projects, Estates and Facilities Team for estates and facilities aspect of these projects. 8.4 The project will be managed in accordance with PRINCE2TM methodology and the project team will seek to manage all the various tasks which can be anticipated in a project of this kind and with a commitment to undertake a post project evaluation. 9 RECOMMENDATION 9.2 The Trust Board is asked to support the capital investment required for the new modular theatre, refurbishment of Theatre 1 & 2 and the conversion of Theatre 3 into a store facility. 9.3 This option enables the Trust to maintain capacity throughout the project programme. Furthermore at the end of the project the potential risk of infection from non compliant theatres will be reduced, an additional theatre will be provided creating an extra ten sessions per week which will contribute to improving patient flow and achievement of the 18 week referral to treatment pathway. The project will also deliver a central store facility which will deliver improved financial control over theatre procurement, stock control and storage. Without the support of both capital and revenue funds to make these improvements the Trust is at significant risk of underperformance, against key targets. Ahmet Koray, Director of Finance Mark Masters, Director of Projects Estates and Facilities Sheila Puckett, Director of Operations & Service Improvement Page 14 of 14
© Copyright 2025 Paperzz